Below are commonly used dosages, but always take the dosage your doctor prescribes
GLP-1 medications are covered and require prior authorization
Nature 542 , 177185 (2017)
Transdermal-specific considerations for patches would include: Local skin reactions (erythema, itching, irritation at application site) Contact dermatitis from adhesive components or penetration enhancers Skin integrity concerns requiring regular site rotation Patient safety advice for anyone using GLP-1 therapy includes: Report persistent severe abdominal pain (potential pancreatitis) Monitor for signs of gallbladder problems (right upper quadrant pain, particularly after meals) Maintain adequate hydration, especially if experiencing vomiting or diarrhoea Contact your GP if side effects are severe, persistent, or concerning Report suspected side effects via the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk) Regarding pregnancy and breastfeeding, advice varies by product
For many women with PCOS and obesity, taking GLP-1 agonists consistently for at least 24 weeks, and losing weight as a result, has been shown to help restore regular periods
Treatment recommendations, when clinically appropriate, require provider evaluation and supervision by a licensed healthcare provider